Three-year results of the RESOLUTE trial include no new target lesion revascularisations and no instances of stent thrombosis.

[more]

Since the first percutaneous implantation of a pulmonary valve in a human was reported for the first time in 2000, transcatheter heart valve procedures have recorded constant double-digit growth year-on-year, offering a new option to candidates not suitable for conventional surgery.

[more]

The results of the ARBITER 6-HALTS trial raised questions and prompted heated discussion at the American Heart Association scientific sessions.

[more]

New guidance recommending the use of prasugrel in combination with aspirin as an option for preventing blood clots in the arteries of people with acute coronary syndromes has been published by the National Institute for Health and Clinical Excellence (NICE).

[more]

The latest progress in traditional heart surgery, minimally invasive and transcatheter techniques were presented in a two-day congress at the Heart Centre, University of Leipzig, Germany.

[more]

OrbusNeich have announced the initiation of patient enrolment in the randomised clinical trial of the Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent).

[more]

Alain Cribier, who performed the first double balloon technique for dilatation of valvular stenosis in 1985, spoke to Cardiovascular News International about the evolution of percutaneous techniques.

[more]

Carlo Briguori, Naples, Italy, discusses the difficulties in compliance and low response to dual antiplatelet therapy.

[more]

Kornelia Kotseva, Imperial College, London, UK, analyses the results of the EUROASPIRE surveys.

[more]

Andre Rubboli, Bologna, Italy, analyses a polymer-free, Carbofilm coated stent eluting tacrolimus from abluminal reservoirs, which has been widely tested in patients with either stable or unstable coronary artery disease.

[more]

Jamie S Sutherell, cardiology fellow at Cincinnati’s Children Hospital, US, analysis the lack of paediatric medical devices and off-label use.

[more]

Dr Dirk J van Veldhuisen analyses the findings on the use of CRT for heart failure patients classes I and II and how the results will impact in future studies.

[more]

Alfredo R Galassi, director of diagnostic and cardiovascular interventional laboratory, Ferrarotto Hospital University of Catania, Italy, and associate professor of cardiology, University of Catania, Italy, tells Cardiovascular News International about his career journey to date, and his love of sailing

[more]

Silvia G Priori spoke to Cardiovascular News about her career, research, joy in spending time with her two children, and the occasion she took beta-blockers before meeting Dr Mike Rosen.

[more]

Cardiovascular News talks to Professor Christian Hamm, Bad Nauheim, Germany, about his influences, current areas of research, and the challenges facing cardiology.

[more]

Professor Fausto Pinto discusses his major influences, his career achievements and his passion for travelling, books and music.

[more]

The US Food and Drug Administration has approved Thoratec’s PMA (pre-market approval) supplement, allowing the use of its HeartMate II left ventricular assist system for destination therapy.

[more]

The everolimus-eluting stent, Xience V has been approved by the Japanese Ministry of Health, Labour and Welfare (MHLW), Abbott has announced.

[more]

Mega has a smaller insertion point than traditional 50cc intra-aortic balloons and offers additional blood volume displacement for intra-aortic balloon counterpulsation.

[more]

Boston Scientific announced on 21 September 2009 release of its CE-marked, next-generation iLab System Software for the iLab Ultrasound Imaging System.

[more]